Genomic alterations in CCND2 are reported in multiple malignances including renal cell carcinoma (48) and colon cancer (49) and CCND2 overexpression is related to poor overall survival in patients with gastric cancer (50). This evidence concerns the gene CCND2 and gastric cancer.